Basil Ferenczi, MD

Basil Ferenczi, MD, is a board eligible doctor specializing in urologic oncology and robotic surgery. Away from work, Dr. Ferenczi enjoys tennis, hiking, camping, skiing and spending time with family.

The conditions Dr. Ferenczi treats include:

• Kidney cancer
• Prostate cancer
• Bladder cancer
• Testicular cancer
• Kidney stones
• Enlarged prostate

• Ferenczi, Basil A., Chris Baliga, Pascale Akl, Alison Bradywood, Craig Blackmore, Michael Glenn, Donna Smith, Gary Kaplan, and John M. Corman. "Pre-procedural Covid-19 screening of asymptomatic patients: a model for protecting patients, community and staff during expansion of surgical care." NEJM Catalyst Innovations in Care Delivery 1, no. 3 (2020).
• Ferenczi, Basil A., Ron Ron Cheng, Adam Daily, Christian Kuhr, Kathleen Kobashi, and John M. Corman. "Pre-operative COVID-19 screening: a model to provide non-discretionary care for urologic patients." International braz j urol 47 (2021): 631-636.
• Kord, Eyal, Basil Ferenczi, Renzo G. DiNatale, Adam Daily, Hannah Koenig, Jason Frankel, Nathan Jung, John Paul Flores, and Christopher Porter. "Are high-risk prostate cancer patients being treated equally? The impact of PSA." In Urologic Oncology: Seminars and Original Investigations, vol. 41, no. 4, pp. 204-e17. Elsevier, 2023.
• Ferenczi, Basil, Wai Lee, Jason Frankel, Christopher Porter, and John Corman. "Anti-Tobacco Advertising—Is Bladder Cancer Adequately Addressed?." Urology Practice 8, no. 4 (2021): 450-453.
• Stamm, Andrew, Basil Ferenczi, Christopher Porter, Paul Kozlowski, Ryan Donahue, and John Corman. "Impact of catheter size on pain and continence following robotic prostatectomy." The Canadian Journal of Urology 27, no. 5 (2020): 10363-10368.
• Ferenczi, Basil, Jason Frankel, Nathan Jung, Christopher Porter, and John Paul Flores. "Effect of PSA on equal treatment of high-risk patients." (2020): e17514-e17514.